Protocol SYN115-CL02: A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of SYN115 as Adjunctive Therapy in Levodopa-Treated Parkinson's Subjects with End of Dose Wearing off"

Project: Research project

Project Details

StatusFinished
Effective start/end date4/14/114/14/14

Funding

  • PRA Health Sciences (Protocol SYN115-CL02)
  • Biotie Therapies, Inc. (Protocol SYN115-CL02)